A CLINICAL TRIAL COMPARING THE EFFICACY OF TENOFOVIR DISOPROXIL FUMARATE/EMTRICITABINE/RILPIVIRINE (TDF/FTC/RPV) VERSUS TDF/FTC/EFAVIRENZ (TDF/FTC/EFV) IN PATIENTS WITH UNDETECTABLE PLASMA HIV-1 RNA ON CURRENT FIRST-LINE TREATMENT: